Prion Protein Monoclonal Antibody Therapy for Creutzfeldt–Jakob Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme
Lancet Neurol 2022 Apr 01;21(4)342-354, S Mead, A Khalili-Shirazi, C Potter, T Mok, A Nihat, H Hyare, S Canning, C Schmidt, T Campbell, L Darwent, N Muirhead, N Ebsworth, P Hextall, M Wakeling, J Linehan, V Libri, B Williams, Z Jaunmuktane, S Brandner, P Rudge, J CollingeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.